BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 4218049)

  • 1. Inhibition of the diuretic action of glibenclamide by clofibrate, carbamazepine and 1-deamino-8-d-arginine-vasopressin (DDAVP) in patients with pituitary diabetes insipidus.
    Radó JP; Szende L; Marosi J; Juhos E; Sawinsky I; Takó J
    Acta Diabetol Lat; 1974; 11(3):179-97. PubMed ID: 4218049
    [No Abstract]   [Full Text] [Related]  

  • 2. Antidiuretic effect of clofibrate and carbamazepine in diabetes insipidus: studies on free water clearance and response to a water load.
    Bonnici F
    Clin Endocrinol (Oxf); 1973 Jul; 2(3):265-75. PubMed ID: 4760548
    [No Abstract]   [Full Text] [Related]  

  • 3. [Diabetes insipidus. Clinico-pharmalogical correlations and their therapeutic results with various substances].
    Holgado Silva C; De la Vega Vázquez JM; Bolaños Díaz A; Fajardo Gálvez J; Aznar Reig A
    Rev Clin Esp; 1978 Feb; 148(4):381-4. PubMed ID: 653059
    [No Abstract]   [Full Text] [Related]  

  • 4. Paradoxical diuresis after vasopressin administration to patients with neurohypophyseal diabetes insipidus treated with chlorpropamide, carbamazepine or clofibrate.
    Meinders AE; van Leeuwen AM; Borst JG; Cejka V
    Clin Sci Mol Med; 1975 Oct; 49(4):283-90. PubMed ID: 1192687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolongation of duration of action of 1-deamino-8-D-arginine vasopressin (DDAVP) by ineffective doses of clofibrate in diabetes insipidus.
    Radó JP; Marosi J
    Horm Metab Res; 1975 Nov; 7(6):527-8. PubMed ID: 1213665
    [No Abstract]   [Full Text] [Related]  

  • 6. Evidence for permanent enhancement of residual ADH induced by antidiuretic agents (chlorpropamide, carbamazepine, clofibrate) in patients with pituitary diabetes insipidus.
    Radó JP
    Endokrinologie; 1975 Jan; 64(2):217-22. PubMed ID: 1149696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current management of diabetes insipidus.
    Hsu TH
    Compr Ther; 1980 Aug; 6(8):22-5. PubMed ID: 7408432
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of diabetes insipidus with carbamazepine.
    Wales JK
    Lancet; 1975 Nov; 2(7942):948-51. PubMed ID: 53432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lengthening of the duration of action of DDAVP by "ineffective" doses of clofibrate in patients with pituitary diabetes insipidus.
    Radó JP; Marosi J
    Endokrinologie; 1976 Jun; 67(2):220-9. PubMed ID: 954691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of diabetes insipidus with DDAVP.
    Kikugawa CA; Cortopassi RF; Ditmer DG; Okamoto WS
    Am J Hosp Pharm; 1977 Sep; 34(9):1013-7. PubMed ID: 906988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative evaluation of antidiuretic preparations used in treating diabetes insipidus patients].
    Kolomoĭskaia MB; Latypova GA
    Vrach Delo; 1984 Apr; (4):76-9. PubMed ID: 6204458
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of carbamazepine and clofibrate antidiuretic effect by mannitol osmolar clearance.
    Simon J; Zamora I; Mendizabal S; Bartolome V
    Helv Paediatr Acta; 1979 Sep; 34(4):329-38. PubMed ID: 521299
    [No Abstract]   [Full Text] [Related]  

  • 13. [Drug therapy of diabetes insipidus].
    Quist Paulsen A
    Tidsskr Nor Laegeforen; 1976 Aug; 96(23):1222-3. PubMed ID: 968848
    [No Abstract]   [Full Text] [Related]  

  • 14. Individual differences in the antidiuretic response induced by single doses of 1-deamino-8-D-arginine-vasopressin (DDAVP) in patients with pituitary diabetes insipidus.
    Radó JP; Marosi J; Borbély L; Takó J
    Int J Clin Pharmacol Biopharm; 1976 Dec; 14(4):259-65. PubMed ID: 1002361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1-deamino-8-D-arginine vasopressin in the treatment of central diabetes insipidus in childhood.
    Becker DJ; Foley TP
    J Pediatr; 1978 Jun; 92(6):1011-5. PubMed ID: 660339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of glyburide on the antidiuretic response induced by 1-deamino-8-D-arginine vasopressin (DDAVP) in patients with pituitary diabetes insipidus.
    Radó JR; Szende L; Marosi J
    Metabolism; 1974 Nov; 23(11):1057-63. PubMed ID: 4214480
    [No Abstract]   [Full Text] [Related]  

  • 17. Letter: Treatment of diabetes insipidus.
    Bonnici F
    S Afr Med J; 1974 Jun; 48(26):1094. PubMed ID: 4843487
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical value of the combinations of carbamazepine (tegretol), chlorpropamide (diabinese) and vasopressin in the treatment of pituitary diabetes insipidus.
    Radó JP; Marosi J; Szende L; Takó J
    Endokrinologie; 1973 Dec; 62(3):297-309. PubMed ID: 4790811
    [No Abstract]   [Full Text] [Related]  

  • 19. [Further studies of antidiuresis induced with carbamyldibenzoazapine and with ethyl parachlorophenoxyisobutyrate in diabetes insipidus].
    Borghetti A; Novarini A; Borghi L; Canali M; Coruzzi P; Pasetti GC
    Clin Ter; 1976 Mar; 76(6):553-62. PubMed ID: 1017156
    [No Abstract]   [Full Text] [Related]  

  • 20. Antidiuretic effect of clofibrate in therapy of diabetes insipidus.
    de Gennes JL; Bigorie B; Bertrand C; Truffert J
    Horm Metab Res; 1973 Nov; 5(6):461-6. PubMed ID: 4588116
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.